Polymer-Protein Bioconjugate Materials by Tchoul, Oksana Daria
   POLYMER-PROTEIN BIOCONJUGATE MATERIALS  
    
    
 
 
   By 
   OKSANA DARIA TCHOUL 
   Bachelor of Science in Chemical Engineering  
    Belarussian State Technological University 
   Minsk, Belarus 
   1992 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   MASTER OF SCIENCE 
   May, 2009 
 
 ii
   POLYMER-PROTEIN BIOCONJUGATE MATERIALS  






   Thesis Approved: 
 
 
   Dr. Jeffery L. White 
   Thesis Adviser 
 
   Dr. Warren T. Ford 
 
   Dr. Ziad El Rassi 
 
  Dr. A. Gordon Emslie 






 iii  
ACKNOWLEDGMENTS 
 
I would like to express my sincere gratitude to my adviser, Professor Jeffe y L. White for 
allowing me to join his group, for his attention, guidance, and support during my course 
of study and for his help and suggestion during the preparation of the current Thesis. I 
also thank the members of my Committee, Professors Warren T. Ford and Ziad El Rassi 
for advising me in my research project. I am very grateful to my friends from the Dr. 
White’s group: Rosimar, Matthew, Lance and Erik, who were very supportive to me in 
every way. 
And last but not least, I would like to thank my husband Maxim for sharing his 
experience with me and my children Slava and Misha for their efforts to keep quiet while 
I was writing this Thesis.  
 
 iv
TABLE OF CONTENTS 
 
Chapter          Page 
 
I. INTRODUCTION ......................................................................................................1 
 
 Bioconjugate materials in medicine .........................................................................1 
 Functionalization methods in bioconjugate chemistry ............................................4 
 
 
II. SCOPE AND OBJECTIVE OF THE RESEARCH ..................................................6 
  
 Hemoperfusion .........................................................................................................6 
 Objective of the project and research strategy .........................................................7 
 
 
III. EXPERIMENTAL SECTION ...............................................................................13 
 
 Materials ................................................................................................................13 
 Instruments .............................................................................................................13 
 Synthesis of the crosslinked poly(HEMA-co PEGDMA) .....................................14 
 Oxidation of poly(HEMA-co-PEGDMA) .............................................................14 
 Conjugation of the oxidized poly(HEMA-co-PEGDMA) with oligopeptides ......15 
 
 v
Chapter          Page 
 
 Acrylation of poly(HEMA-co-PEGDMA) ............................................................15 
 Conjugation of acrylated poly(HEMA-co-PEGDMA) with oligopeptides ...........15 
 Conjugation of oxidized poly(HEMA-co-PEGDMA) with glucose oxidaze ........16 
 Synthesis of poly(CEA-co-PEGDMA) ..................................................................16 
 Functionalization of poly(CEA-co-PEGDMA) with N-hydroxysuccinimide .......17 
 Conjugation of the NHS-modified poly(CEA-co-PEGDMA) with glucose 
  oxidaze ..................................................................................................................17 
 Enzymatic activity of the glucose oxidase conjugated with crosslinked 
  copolymers ............................................................................................................17 
 Lifetime enzymatic activity ...................................................................................18 
 
 
IV. RESULTS AND DISCUSSION ............................................................................19 
 
 Synthesis and functionalization of the crosslinked copolymers ............................19 
 Conjugation of the crosslinked copolymers with oligopeptides ............................22 
 Conjugation of the crosslinked copolymers with glucose oxidase ........................28 
 Lifetime enzymatic activity of the polymer immobilized glucose oxidase ...........31 
 
 





LIST OF TABLES 
 
 
Table           Page 
 
   1. Mass change in crosslinked polymers after reactions with oligopeptides ............27 
   2. Elemental analysis results for the conjugated crosslinked polymers ....................28 
   3. Relative enzymatic activity of Glucose Oxidase grafted polymers ......................31 
 
 vii
LIST OF FIGURES 
 
Figure           Page 
 
   1. FTIR spectra of the poly(HEMA-co-PEGDMA) after the synthesis and after  
oxidation with PCC ................................................................................................20 
   2. FTIR spectra of poly(HEMA-co-PEGDMA) before and after reaction with 
acryloyl chloride  ...................................................................................................21 
   3. FTIR spectrum of the aldehyde modified polymer 2 conjugated with reduced 
L-glutathione ..........................................................................................................23 
   4. 13C solid state NMR spectra of poly(HEMA-co-PEGDMA) before and after 
conjugation with glucose oxidase ..........................................................................29 
   5. Lifetime enzymatic activity of glucose oxidase grafted to the polymers .............32 
 
 viii  
LIST OF SCHEMES 
 
Scheme          Page 
 
   1. Common conjugation reactions ..............................................................................5 
   2. Synthesis and modification of poly(2-hydroxyethyl methacrylate-co- 
poly(ethylene glycol) methacrylate). .......................................................................9 
   3. Synthesis and modification of poly(2-carboxyethyl acrylate-co-poly(ethylene 
glycol methacrylate)...............................................................................................10 
   4. Chemical reactions involved in determination of the enzymatic activity of 
glucose oxidase by Stanbio assay ..........................................................................12 
   5. Structures of oligopeptides ...................................................................................24 





    INTRODUCTION 
 
Bioconjugate materials in medicine 
 The term “biocongugate materials” refers to the hybrid materials composed of 
biological molecules, such as antibodies, nucleic acids, lipids, carbohydrates, chemically 
joined with synthetic molecules, such as drugs, toxins, or fluorophores. In this class of 
materials, polymer-protein conjugates particularly stand out due to a variety of 
applications in the modern science and technology.1 For example, polypeptides 
immobilized on an inert solid support are used in sensors2 and biocatalyst systems 
(immobilized enzymes).3 In medicine, polymeric bioconjugates are studied as prospective 
systems for tissue engineering and controlled drug release.4  
Tissue engineering is the use of a combination of cells, engineering and materials 
methods, and suitable biochemical and physico-chemical factors to impr ve or replace 
biological functions. Bioconjugate materials in this area are utilized in the form of 
implantable scaffolds, where biodegradable polymers, such as poly(L-lactic acid), 
polyglycolic acid, polycaprolactone, or polyphosphazenes are functionalized w th growth 
factor proteins for the restoration or regeneration of living tissues.5,6 There are two 
strategies in application of the scaffolds: the closed system and the open system strategy. 
In a closed system, scaffolds are encapsulated using a semipermeable membrane that 
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protects cells from host immune response and allows nutrient transport and waste 
removal. In the open system, scaffolds are precultured in vitro before implantation. The 
required properties of scaffolds are biocompatibility, bioactivity, biodegradability and 
non-toxic nature of the products of degradation. Biocompatibility is support of cellular 
activity without inducing negative effect, such as tissue rejection.7 Bioactivity is the 
ability of the scaffold to favor cell attachment, proliferation ad differentiation.8 
Controlled biodegradability is an important factor as well, because the rate of degradation 
of scaffold should be consistent with the formation of new tissue. The use of 
biodegradable scaffolds alone with cells and growth factors has shown a success in 
regeneration of skin, blood vessels, bone and heart valves.1 
In controlled drug release, metabolically degradable composition of the synthetic 
polymer covalently linked to a biologically active compound is employed. Slow 
decomposition of the conjugate enables the administration of the drug over an extended 
period of time, thus ensuring a constant concentration of the active ingrdient in the 
bloodstream and the prolonged therapeutic effect. The controlled release mechanism also 
provides protection for the active molecules, especially peptide and nucleic a id based 
agents, from degradation and unwanted interaction. Protection is especially necessary if a 
medicine is administered orally, because the drug must pass a series of biological and 
physiological barriers before reaching its target.  
Two basic mechanisms are implemented in controlled drug release approach. In 
the first mechanism, the slow metabolic degradation of the matrix polymer releases the 
active compound. Poly(L-lactic acid),9 poly(ethylene oxide)-co-(lactic acid),10 
polyanhydrides11 and polyphosphazenes12 are used for this purpose. For example, poly(L-
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lactic acid) and polyglycolic acid  undergo hydrolysis under normal physiological 
conditions. Lactic and glycolic acids are released, and the results of such hydrolysis are 
normal products of human metabolism which do not possess an adverse toxicological 
effect. The half-life of degradation for poly[(lactic acid)-co-(glycolic acid)] (PLGA) 
normally ranges from 10 to 20 weeks, depending on composition of the copolymer.13 
Addition of the drug affects the degradation rate of the polymer matix. Thus, PLGA 
copolymer loaded with 2 wt% of diazepam decomposed by 35% in 20 days, releasing the 
corresponding fraction of the active ingredient.14  
The second mechanism of the controlled release involves cleavage of the linker 
between the matrix and the active molecule. The linker is usually an oligopeptide that is 
subjected to enzymatic degradation in the body. For example, Seliktar t al.15 employed a 
protease-sensitive 8-peptide linker to attach the vascular growth factor to the 
poly(ethylene glycol) hydrogel in the preparation of a conjugate material aimed at blood 
vessel wall restoration. Leach and Schmidt16 have demonstrated the use of hyaluronic 
acid as a linker between the polymer scaffold and the protein. Hyaluronic acid (or 
hyaluronan) is a natural disaccharide, distributed widely throughout connective, 
epithelial, and neural tissues. In both examples the linking molecules were slowly 
digested during metabolism. At the present time poly(ethylene glycol) is the most 






Functionalization methods in bioconjugate chemistry 
Scheme 1 represents common conjugation schemes.20,22-24 Functionalization of 
poly(ethylene glycol) or poly(hydroxyethyl methacrylate) with divinyl sulfone in aqueous 
solution at pH 10 introduces vinyl sulfone and α,β-unsaturated carbonyl functionalities to 
the polymer.23 Both groups can easily react with thiols at pH 8 or amines at pH 9 via 
Michael addition, resulting in conjugation with proteins.23 Another method of introducing 
unsaturated carbonyls to the polymer is esterification of its hydrox ls with acryloyl 
chloride, which is performed in dichloromethane at room temperature.20  
Conjugation of proteins to the amine containing matrix polymers can be also 
performed via maleimide-thiol reaction. Maleimide groups are introduce  to the polymer 
by reaction with maleimide-N-succinimidyl crosslinking reagents.22  N-hydroxy 
succinimidyl ester (NHS-ester) chemistry is a convenient rou e for conjugation of the 
carboxyl-terminated polymers. Esterification of carboxyl groups with N-hydroxy 
succinimide results in the formation of “active esters”,24, 25 which are highly reactive 
toward primary amines of the corresponding protein.  
Preliminary functionalization of both protein and polymer with the “click” 
chemistry-enabled functional groups is an effective although less common method. For 
example, in the work of Dirks et al.26 the target oligopeptide was first treated with N-
propyl maleimide to attach alkyne groups, which further reacted with the azide-
terminated polystyrene to yield the oligopeptide-polystyrene complex. In another 
example, by Heredia et al.,17 the ketone functionalities were introduced to bovine serum 
albumin, enabling the conjugation with the various aminooxy-terminated acrylic 
 5
polymers. The primary factor that should be taken in account is choosing the conjugation 
technique is the ability of the immobilized protein to retain its biological activity. 
 
Scheme 1. Common conjugation reactions. 
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SCOPE AND OBJECTIVE OF THE RESEARCH 
 
Hemoperfusion 
Hemoperfusion has been used for many years for removal of toxic substance  
from the patient’s blood.27,28 Hemoperfusion is essential for the treatment of intoxicated 
or poisoned patients in emergency situations, for removal of waste products from the 
blood of the patients with acute renal failure, as well as a supportive treatment before and 
after liver transplantation.27, 28 In this extensive care procedure the blood passing through 
the purification apparatus directly perfuses the particles that bind specific toxins. 
Originally, charcoal was used as a filtration media, but recently polymeric beads with 
immobilized drugs and antibodies for removal of toxins have been introduced.28-30 For 
example, polymyxin-functionalized fibrous columns are commonly used to prevent sepsis
in surgical procedures,29 and to treat inflammatory response syndrome.31 Polymyxin B is 
an antibiotic that is highly efficient in binding and inactivation of endotoxin and is also 
bactericidal for gram negative bacteria, which defines the use of this drug in filtration 
media for hemoperfusion. Another example of a bioconjugate material for blood 
treatment is given in the work of Azhari,30 that describes a material for emergency 
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treatment of patients poisoned with herbicide Paraquat. Specific antiparaquat antibodies 
were covalently bound to cross-linked agarose-polyacrolein microsphere beads. The 
material removed Paraquat from the bloodstream of the dog during hemoperfusion 
session 4 times faster than a regular charcoal column. 
 
Objective of the project and research strategy 
The objective of the current research project was to develop a synthetic 
bioconjugation method that could be potentially utilized to produce active filtration 
materials for hemoperfusion. The novelty of this work is the use of acrylic ester polymers 
as the material of choice for immobilization of the biologically ctive compounds. As it 
was mentioned above, charcoal has been the most common filter in hemoperfusi n 
methods, while conjugated polymers are being introduced only recently. Acr lic 
polymers are chemically and biologically inert, insoluble, have a low degree of swelling 
in water and are already used for producing various parts of blood purification 
equipment. Copolymerization of different monomers with specific functio al groups 
allows modification of the surface of the resulted polymeric particles for further 
functionalization with the required moieties, using well established techniques of 
bioconjugate chemistry. 
In the present work, crosslinked copolymers poly(hydroxyethyl methacrylate-co-
poly(ethylene glycol) dimethacrylate) (poly(HEMA-co-PEGDMA)) and 
poly(carboxyethyl acrylate-co-poly(ethylene glycol) dimethacrylate) (poly(CEA-co
PEGDMA)) were used. The surface of the polymer particles was modified by different 
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methods in order to chemically attach biomolecules. Schemes 2 and 3 outline the 
synthetic procedures for the preparation and surface functionalization of poly(HEMA-co-
PEGDMA) and poly(CEA-co-PEGDMA) correspondingly. 
 To test the conjugation techniques, L-glutathione (Glutamyl-Cysteinyl-Glycine) 
in its reduced and oxidized forms and L-carnosine were used as exampls of 
polypeptides. Conjugation was performed by three methods. In the first method, the -OH 
groups of HEMA were oxidized to aldehydes, which further reacted with –SH groups of 
L-glutathione resulting in thioacetal bond formation between polypeptide an  copolymer. 
In the second method the copolymer was acrylated via reaction of -OH groups of HEMA 
with acryloyl chloride. This procedure introduced α,β-unsaturated carbonyls to the 
surface of the polymer which further reacted with -SH groups of the polypeptide.20 This 
reaction has been used previously for the PEG-peptide conjugates.16,18-21 In order to 
investigate the efficacy of reaction of the cysteine -SH groups vs. amine groups of 
protein, the cysteine-free oligopeptide L-Carnosine (beta-alanyl-L-histidine) was tested. 
The third conjugation method was based on reaction of the N-hydroxysuccinimide-
functionalized polymer with amine groups of the protein.24  
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Scheme 2. Synthesis and modification of poly(2-hydroxyethyl methacrylate-co-

















































































































In order to examine the biological activity of the immobilized protein, glucose 
oxidase has been chosen due to simplicity of the activity determination for this enzyme. 
Two cross-linked polymers, poly(HEMA-co-PEGDMA) and poly(CEA-co-PEGDMA), 
were used as a support. In the first polymer the surface -OH groups were oxidized to 
aldehydes and in the second polymer carboxylic groups were esterifid with N-
hydroxysuccinimide. Activity of the polymer-bonded enzyme was studied by the 
modified Stanbio enzymatic glucose assay with free Horseradish Peroxidase (Hp).32  
Scheme 4 shows the reactions involved in the analysis of enzymatic activity. In 
the first step glucose oxidase reacts with glucose yielding gluconic acid and hydrogen 
peroxide.33 The amount of hydrogen peroxide evolving during this step is directly 
proportional to the activity of the enzyme. In order to estimate this amount, the color 
reaction with Stanbio assay, containing Horseredish peroxidase, 4-aminoantipyrine, and 
p-hydroxybenzenesulfonate, is employed. Oxidation of 4-aminoantipyrine with hydrogen 
peroxide, catalyzed by Horseredish peroxidase in the presence of p-hydrozybenzene 
sulfonate, produces the red-colored quinoneimine complex. The amount of the c mplex, 
measured by UV absorption at 500 nm, is proportional to the concentratio  of hydrogen 
peroxide and, therefore, to the activity of glucose oxidase. 
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Scheme 4. Chemical reactions involved in determination of the enzymatic activity 









All the chemicals were purchased from Aldrich. Poly(ethylene glycol) 
dimethacrylate with average Mn of the poly(ethylene glycol) chains of 300 Da 
(PEGDMA) and 2-hydroxyethyl methacrylate (HEMA) monomers were purified from 
inhibitor by passing through basic alumina. All other chemicals were used as received. 
Double processed sterile deionized water (pH=6.7) was used for all the experiments that 
involved oligopeptides or glucose oxidase. 
 
Instruments 
The 13C NMR spectra were taken on a 300 MHz Bruker DSX solid state NMR 
spectrometer. FTIR analysis was performed on a Varian 800 FTIR Spectrometer. UV-
VIS spectra were acquired on a CARY 5000 UV-VIS-NIR spectrometer. The pH of the 
buffer solutions was measured on Mettler-Toledo pH-meter. The elemental analysis of 




Synthesis of the crosslinked poly(HEMA-co-PEGDMA) 
 For the experiment, 1 g of polyvinylpyrrolidone was dissolved in 115 ml of water 
and the solution was transferred into a 500 ml 3-neck round bottom flask equipp d with 
nitrogen inlet and outlet, mechanical stirrer, and reflux condenser. The solution was 
purged with nitrogen for 10 min to eliminate oxygen. A mixture of 25 ml (200 mmol) of 
HEMA, 3.1 ml (10 mmol) of PEGDMA, and 0.5 g (3.05 mmol) of 2,2′-azobis(2-
methylpropionitrile) (AIBN) in 25 ml of toluene was added to the flask and the reaction 
mixture was stirred at 70 0C for 5 h in a nitrogen atmosphere. The resulting suspension 
was filtered through the Whatman #54 paper filter and the solid was hed 
consecutively with excess water, acetone, and methanol, yielding the crosslinked 
copolymer 1 (Scheme 2). The sample of the product for the FTIR and NMR spectroscopy 
was dried in vacuum at room temperature for 24 h. 
 
Oxidation of poly(HEMA-co-PEGDMA) 
1.5 g of pyridinium chlorochromate (PCC) was dissolved in 60 ml of 
dichloromethane and transferred into a 100 ml two-neck round flask under nitroge 
atmosphere. 2.8 g of polymer 1, taken immediately after the synthesis and purification, 
was washed with dichloromethane and added to the flask, and the mixture was stirred at 
45 0C under nitrogen until the solution color changed to brown-green. The solid was 
filtered through the paper filter and washed with dichloromethane until the filtrate was 
clear, yielding polymer 2. The sample for spectroscopy was dried under vacuum at room 
temperature for 24 h. 
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Conjugation of the oxidized poly(HEMA-co-PEGDMA) with oligopeptides 
Three different oligopeptides: L-carnosine, and L-glutathione in both reduced and 
oxidized form, were used for this experiment. Reaction was performed both in deionized 
water (pH 6.7) and in phosphate buffer saline (pH 8.2). Copolymer 2 in the amount of 1.8 
g was added to the 40 ml of the 20 mg/ml solution of the oligopeptide in a 100 ml beaker 
and the mixture was stirred at room temperature for 2 h. The resulting product was 
filtered, rinsed with water, and dried under vacuum at room temperature for 24 h. 
 
Acrylation of poly(HEMA-co-PEGDMA) 
The synthesis was performed according to the procedure described previously for 
acrylation of PEG.21 30 g of polymer 1 taken immediately after the synthesis and 
purification was washed with dichloromethane and transferred into a 500 ml round-
bottomed flask containing 300 ml of dichloromethane. The mixture was cooled to 0 °C in 
an ice bath. 13.1 ml of triethylamine and 15.8 ml of acryloyl chloride were added to the 
flask, and the reaction mixture was stirred for 12 h at 0 °C followed by stirring for 12 h at 
room temperature under nitrogen atmosphere. The resulting product was filtered and 
washed with dry dichloromethane and tetrahydrofuran, yielding polymer 3 (Scheme 2). 
The sample for spectroscopy was dried in vacuum at room temperature for 24 h. 
 
Conjugation of acrylated poly(HEMA-co-PEGDMA) with oligopeptides 
Three different oligopeptides: L-carnosine, and L-glutathione in both reduced and 
oxidized form, were used for this experiment. 0.84 g of peptide was dissolved in 20 ml of 
the phosphate buffer solution (K2HPO4/KH2PO4, pH=8.14) and 1.6 g of polymer 3 was 
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added to the solution and mixed immediately. The reaction was stirred for 2 h at room 
temperature. The resulting glutathione–copolymer conjugate was washed and dried under 
vacuum at room temperature for 24 h. 
 
Conjugation of oxidized poly(HEMA-co-PEGDMA) with glucose oxidase 
Glucose oxidase (GOx) in the amount of 0.18 g was dissolved in 4 ml of water in 
a test tube and 1.51 g of polymer 2 was added to the solution. Reaction was carried out at 
37 °C for 30 min for enzyme activation followed by additional 2 h at 3 °C. The resulting 
conjugate was washed by centrifugation several times until no GOx was detected in the 
supernatant by UV-VIS spectroscopy. The solid product was dried at room temperature 
under vacuum for 4 h and stored at – 30 oC. 
 
Synthesis of poly(2-carboxyethyl acrylate-co-poly(ethylene glycol) dimethacrylate) 
(poly(CEA-co-PEGDMA)) 
1 g of polyvinylpyrrolidone was dissolved in 115 ml of water and the solution was 
transferred into a 500 ml 3-neck round bottom flask equipped with a nitrogen inlet and 
outlet, mechanical stirrer, and reflux condenser. The solution was purged with nitrogen 
for 10 min to eliminate oxygen. A mixture of 23.7 ml (200 mmol) of carboxyethyl 
acrylate, 3.1 ml (10 mmol) of PEGDMA, and 0.5 g (3.05 mmol) of AIBN in 25 ml of 
toluene was added to the flask and the reaction mixture was stirred at 70 0C for 5 h in a 
nitrogen atmosphere. The resulting suspension was filtered and the solid was washed 
consecutively with excess water, acetone, and methanol, yielding the crosslinked 
copolymer 4 (Scheme 3). 
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Functionalization of poly(CEA-co-PEGDMA) with N-hydroxysuccinimide 
N-hydroxysuccinimide (NHS) in the amount of 16.48 g was dissolved in 50 ml of
deionized water and 8.2 g of poly(CEA-co-PEGDMA) was added to the solution. The 
mixture was stirred for 30 min. The NHS-modified polymer 5 was filtered and dried 
under vacuum at room temperature for 24 h. 
 
Conjugation of the NHS-modified poly(CEA-co-PEGDMA) with glucose oxidase 
Glucose oxidase (GOx) in the amount of 0.147 g was dissolved in 3 ml of water
in a test tube and 0.483 g of polymer 5 was added to the solution. Reaction was carried 
out at 37 °C for 30 min for enzyme activation followed by additional 2 h at 3 °C. The 
resulting conjugate was washed by centrifugation several times until no GOx was 
detected in the supernatant by UV-VIS spectroscopy. The solid pro uct was dried at 
room temperature under vacuum for 4 h and stored at – 30 oC. 
 
Enzymatic activity of the glucose oxidase conjugated with crosslinked copolymers 
The measurements of the GOx activity were performed by the modified Stanbio 
glucose assay. The assay reagent was prepared by dissolving 152.4 mg of 4-
aminoantipyrine, 174 mg of p-hydroxybenzene sodium sulfonate and 5 mg (100 units) of 
Horseradish peroxidase in 50 ml of double processed sterile deionized wat r (pH=6.7). In 
a typical experiment, 33 mg of the GOx-conjugated polymer was placed in a test tube, 2 
ml of the 1.92 mg/ml solution of glucose was added and the mixture was incubated at 37 
oC for 30 or 60 min. In the control experiment, 7 mg of GOx was used instead of the 
polymer. After incubation, 2 ml of the assay reagent was added to theest tube and after 
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15 min of incubation the absorption of the solution at 500 nm was measured. The mixture 
of 2 ml of the 1.92 mg/ml glucose solution and 2 ml of the assay reagent was used as a 
blank sample for the UV-VIS measurements. 
 
Lifetime enzymatic activity 
After enzymatic activity experiment the sample of the GOx-conjugated polymer 
was separated by centrifugation, washed with water, and placed in the freezer at -30 oC. 
After 24 hours the sample was retrieved and one more enzymatic activity test was 
performed, after which the sample was recovered and stored in the freez r. Such a cycle 




RESULTS AND DISCUSSION 
 
Synthesis and functionalization of the crosslinked copolymers 
The synthetic procedures are outlined in Schemes 2 and 3. Mild oxidatin with 
pyridinium chlorochromate is a well established synthetic method for conversion of 
alcohols to aldehydes.34 Reaction of aldehydes with amines is widely used for cross-
linking proteins.25 The FTIR spectra of poly(HEMA-co-PEGDMA) before and after 
oxidation with PCC are presented in Figure 1. Appearance of the new peak at 1630 cm-1 
corresponding to the vibrations of C=O bonds in aldehyde groups indicates the oxidation 
of the alcohols on the poly(HEMA) chains to aldehydes. Low intensity of the peak 
suggests that the polymer particles poorly swelled in dichloromethan  and only the 
hydroxyl groups exposed on the surface oxidized. 
Cross-linking of proteins via reaction of sulfhydryl or amine groups of proteins 
with acrylates is another effective method for preparation of bioconjugated materials.35 
Figure 2 shows the FTIR spectra of poly(HEMA-co-PEGDMA) (1) and acrylated 
poly(HEMA-co-PEGDMA) (3). The new peaks at ca. 1650 cm-1 and 810 cm-1, 
corresponding to the stretching and bending vibrations of the C=C double bonds appear 




Figure 1. FTIR spectra of the poly(HEMA-co-PEGDMA) after the synthesis (1) and 







Figure 2. FTIR spectra of poly(HEMA-co-PEGDMA) before (1) and after (3) reaction 
with acryloyl chloride. Arrows indicate the new peaks at 1650 and 810 cm-1. 
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Conjugation of the crosslinked copolymers with oligopeptides 
In this experiment the oligopeptides were used as a model of proteins in order to 
develop techniques for conjugation of proteins. For that purpose, reaction in neutral or 
slightly basic conditions had to be tested, so that the protein conformati n would not be 
destroyed. The structures of the oligopeptides are shown in Scheme 5. The synthetic 
procedures for conjugation of glutathione with acrylated and oxidized poly(HEMA-co-
PEGDMA) are presented in Scheme 6. The FTIR spectrum of polymer 2 conjugated with 
reduced L-glutathione is shown in Figure 3. A series of new peaks between 1500 and 
1650 cm-1 appearing in this spectrum, compared to that of the polymer before the 
reaction, indicates the presence of amines and amides due to the conjugati  of 
glutathione to the surface of the copolymer particles. At the same ti e, the –S-H thiol 
peak of the reduced glutathione at 2550 cm-1 cannot be seen in the spectrum, suggesting 
that thiols were engaged in the reaction with aldehydes. When the polymer 2 was allowed 
to react with dimerized (oxidized) glutathione and with L-carnosine, both of which lack 
thiol groups, no changes were observed in the FTIR spectra afte reaction. All of these 
facts suggest that thiols, not amines, react with aldehydes on the surface of the polymer 







Figure 3. FTIR spectrum of the aldehyde modified polymer 2 conjugated with reduced 
L-glutathione. The bow indicates new peaks corresponded to glutathione. 
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Results of the mass change in polymer 2 and polymer 3 after reaction with 
oligopeptides are presented in Table 1. In the blank experiment a sample of polymer was 
stirred in water for 2 h followed by drying in vacuum for 24 h at room temperature. 
Negative numbers can be explained by removal of the residue of either PCC or acrylic 
acid and triethylamine not removed in the previous steps, or removal of water under 
vacuum.  The table shows that the reaction of the aldehyde functionalized polymer and 
reduced glutathione resulted in the highest degree of attachment of the ligopeptide, so 
this polymer would be the most effective for the conjugation of proteins. Reaction with 
aldehydes at pH 6.7 was more effective than at pH 8.2. These results are in agreement 
with the FTIR spectroscopy (Fig. 3), that also shows the presence of glutathione in the 
aldehyde-modified copolymer. 
Aldehyde-thiol reaction has not been used in bioconjugate chemistry before. 
However, formaldehyde and glutaraldehyde are routinely used in histology and electron 
microscopy for fixation of specimens, the process aimed to preserve a sample of 
biological material for the examination.36 It is believed that during fixation aldehydes 
react with the amine at the end of the side-chain of lysine and with the nitrogen of a 
peptide linkage, crosslinking the protein molecules into the insoluble structure.37 
However, one should also expect a nucleophilic addition of the thiol arising from cysteine 
residue of the protein to the carbonyl group of glutaraldehyde, resulting in formation of 
thiohemiacetals. It was anticipated that aldehyde groups on the surface of the polymer 
beads would react with oligopeptides the same way. Contrary to our expectations, 
carbonyls on the surface of the oxidized poly(HEMA-co-PEGDMA) did not react with 
amines of glutathione and carnosine. The conjugation took place only with the reduced 
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form of glutathione that possessed -SH groups. Probably, due to a low amunt of 
aldehydes on the surface and hence low reaction rate, the reaction with sulfhydryl groups, 
as being stronger nucleophiles, becomes prevailing. 
 
Table 1. Mass change in crosslinked polymers after reactions with oligopeptides. 




PEGDMA) oxidized (2) 
Blank  - 6.7 
L-Glutathione (reduced) in DI water (pH 6.7) 14.6 
L-Glutathione (reduced) in pH 8.2 buffer 10.2 
L-Glutathione (oxidized) in pH 8.2 buffer - 5.1 
L-Carnosine in pH 8.2 buffer  -3.1 
Poly(HEMA-co-
PEGDMA) acrylated (3) 
Blank - 2.8 
L-Glutathione (reduced) in pH 8.2 buffer 2.7 
L-Glutathione (oxidized) in pH 8.2 buffer - 2.5 
L-Carnosine in pH 8.2 buffer 4.8 
 
The gravimetric results for the acryloyl chloride modified copolymer have shown 
only a small increase in weight after reaction with carnosine and glutathione (reduced). 
Since the FTIR spectroscopy has not revealed the presence of the oligopeptides in these 
materials, we cannot confirm that the conjugation has taken place for the acrylated 
copolymer. Acryloyl chloride chemistry as a bioconjugation method has been developed 
primarily for attaching of proteins to the PEG-based polyhydrogels. Hydrogels are highly 
water permeable, which makes all the functional groups available for the reaction. 
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Conjugation to the insoluble polyHEMA particles, in contrast, is possible mostly on the 
surface. As we can see from the experimental results, aldehyde-t iol chemistry presents a 
great advantage for this type of systems. 
 
Conjugation of the crosslinked copolymers with glucose oxidase 
For this experiment, aldehyde-modified poly(HEMA-co-PEGDMA) and NHS-
modified poly(CEA-co-PEGDMA) were chosen. Esters of N-succinimide are used for 
bioconjugation24 due to their high activity toward primary amines. In the present 
approach, glucose oxidase served as a model of a biologically active protein due to a well 
established method of determination of activity for this enzyme. Elemental analysis was 
used to estimate the degree of attachments of GOx in each polymer. Table 2 shows the 
weight fraction of GOx in each conjugate, calculated from the elem ntal analysis results. 
Based on the detected content of sulfur and nitrogen, which comes only from the protein, 
the fraction of the attached glucose oxidase was found to be 25% by weight in 
poly(HEMA-co-PEGDMA) and 7.7% by weight in poly(CEA-co-PEGDMA).  
 
Table 2. Elemental analysis results for the conjugated crosslinked polymers. 





Glucose Oxidase (GOx) S 0.06 100 
N 7.28 100 
Poly(HEMA-co-PEGDMA)+GOx S 0.0137 27.4 
N 1.24 23.4 
Poly(CEA-co-PEGDMA)+GOx S 0.0046 7.7 





Figure 4. 13C solid state NMR spectra of poly(HEMA-co-PEGDMA) before (1) and after 
(2) conjugation with glucose oxidase. The spinning rate of the probe was 4000 Hz and 
3000 Hz for the samples before and after conjugation, correspondingly. The marked 
peaks in the spectrum 2: a (55, 60 and 65 ppm, peptide bond carbons); b (30 ppm, 
methylene carbons); c (15 ppm, methyl carbons). 
 
 
Figure 4 shows the 13C solid state NMR spectra of the aldehyde-modified 
crosslinked copolymer-peptide conjugate system. A series of new peaks arises in the 
sample after conjugation (spectrum 2): peaks at 55 – 65 ppm corresponding to the  
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-C-CO-, -CO-NH-, and -NH-C- carbons in the peptide bonds, and the peaks at 30 and 15 
ppm, arising from methylene and methyl carbons of the protein respectively. The 
carboxyl and amide carbons contribute to the ester carbon peak at 175 ppm with the 
spinning sideband at 138 ppm in the spectrum of the conjugated material. 
 Table 3 presents the results of the enzymatic activity test for each sample. 
Absorbance of the quinone complex formed during the analysis is directly proportional to 
the enzymatic activity of glucose oxidase in the system. The glucose oxidase 
immobilized on poly(CEA-co-PEGDMA), despite its much lower content, has shown 
significantly higher activity compared to that conjugated to poly(HEMA-co-PEGDMA). 
According to the literature,38 the active site of the glucose oxidase is comprised of flavin 
adenine dinucleotide (FAD) and 3 amino acid residues, tyrosine (Tyr 515) and two 
histidines (His 516, His 559), located in a funnel-shaped cavity. There ar  3 cysteine 
residues in the structure of the enzyme, 2 of which (Cys 187, Cys 228) are involved in the 
disulphide bridge, leaving the single thiol group of Cys 543 available for binding to the 
aldehyde-functionalized polymer. It is possible that the attachment of the glucose oxidase 
to poly(HEMA-co-PEGDMA) results in obstruction of the active site or distortion of its 
conformation. In addition, the protein may be partially destructed or “poisoned” during 
the conjugation with this particular polymer. All of these factors will lead to the lower 
activity of the enzyme. To clarify this issue, more study should be conducted. 
Conjugation to poly(CEA-co-PEGDMA), on the other hand, proceeds via reaction of the 
NHS ester with the primary amines of arginine and lysine residu  of the enzyme. Given 
23 arginines and 15 lysines in the structure of glucose oxidase, ther  is a large variety of 
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possible enzyme conformations on the surface of the polymer and therefore less chance 
for obstruction or distortion of the active site. 
 
Table 3. Relative enzymatic activity of Glucose Oxidase grafted polymers 










at 500 nm, 
Au 
poly(HEMA-co-PEGDMA)-GOx     33.0   25 %     60 0.0321 
    30 0.034 
Poly(CEA-co-PEGDMA)-GOx     33.0    7.7 %     60 0.3837 
    30 0.3921 
GOx       7.0 100 %     60 1.0706 
    30 0.8063 
 
 
Lifetime enzymatic activity of the polymer immobilized glucose oxidaze 
 Enzymes, as natural catalysts, promote the biochemical reactions without 
consuming themselves in the process. The advantage of the enzyme immobil zed on the 
polymer support would be the ability of the multiple use of such material. Lifetime 
enzymatic activity experiment was performed to see how the immobilized enzyme will 
tolerate the conditions of the multiple uses.  After each test th material was recovered 
and stored in the freezer until the next day, when the same test was repeated on it.  
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Figure 5 shows the absorption of the Stanbio assay solution in two series of the 
experiments performed with the two enzyme-conjugated polymers. A much higher 
absorption in the case of the poly(CEA-co-PEGDMA)-GOx complex corresponds to the 
higher activity of the enzyme in this polymer. Moreover, after five consecutive 
experiments glucose oxidase was still viable. The poly(HEMA-co-PEGDMA)-GOx 
complex, in contrast, has revealed very low activity toward oxidation of glucose, which 
was undetectable already in the third cycle. The loss of activity of the enzyme could be 
attributed to the growth of bacteria on the surface of polymer particles that feed on the 


































In the present work a novel method of immobilization of biologically active 
molecules on the solid inert support has been developed. The reactions of aldehyde and 
NHS-ester groups on the surface of polymer particles with thiols and amines of the 
polypeptides provided an effective way of conjugation of proteins to polymers. In 
particular, the aldehyde-thiol chemistry, which has been introduced here for the first time 
as a bioconjugation technique, was found to be the most efficient towards chemical 
attachment of polypeptides. Insoluble poly(HEMA) based microspheres are preferable as 
a filtration media for the continuous flow systems employed in hemoperfusion, due to 
their low swelling in water. At the same time, unlike in hydrogels, the conjugation of this 
material is possible only on the surface of the particles, so the standard techniques, such 
as acryloyl chloride chemistry, may not work for this type of systems. Therefore, 
aldehyde-thiol conjugation method can provide a good substitution for the preparation of 
new biomedical materials. 
The study of the enzymatic activity of glucose oxidase conjugated with polymer 
particles has shown that the activity of the enzyme attached via aldehyde-thiol chemistry 
was significantly impaired compared to that of the NHS-conjugated material. Presumably 
the attachment to thiols either distorts the conformation of the protin r obstructs the 
active site, or affects in other way the viability of the enzyme, which greatly lowers its 
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activity. At this moment it is not clear whether such an effect is specific to this particular 
enzyme or to the aldehyde-thiol conjugation chemistry. In order to understand this 
problem better, reactions of the aldehyde-modified polymer with different enzymes 
should be studied.  
Addition to the NHS-esters, due to reaction only with the primary amine groups 
of the protein, preserves its 3-dimensional structure and retains he biological activity. 
The enzyme attached on the polymer support is not consumed during the biocmical 
reaction, so that it can be used as a catalyst multiple times, and also can be employed in 
the continuous flow systems. This important property opens the possibility for utilizing 
the developed method for producing new bioconjugate materials for medical applications 
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Scope and Method of Study:  
The purpose of this research was to develop a synthetic bioconjugation method 
that could be potentially used to produce active materials for biomedical 
applications, such as hemoperfusion. Cross linked polyHEMA-based copolymers 
were used as a support, where the surface was chemically modified to introduce 
aldehydes and N-hydroxysuccinimide (NHS) esters to attach polypeptides. 
Glucose oxidase was used as an example of a biologically active material to graft 
to the polymer particles. Enzymatic activity analysis was utilized to evaluate 
activity of the immobilized glucose oxidase. 
Findings and Conclusions:   
Introduction of aldehyde and NHS-esters to the surface of polymer particles 
allowed chemical bonding of proteins to the polymer, which was confirmed by 
FTIR and NMR spectroscopy as well as by gravimetry and elem ntal analysis. 
Experiments with the model oligopeptides have shown that aldehydes of the 
polymer preferred reacting with thiols rather than with amines of the 
oligopeptides. Grafting of glucose oxidase was more effective to the aldehyde 
functionalized polymer than to the NHS-ester functionalized polymer. The latter 
polymeric conjugate has shown a higher activity of the immobilized enzyme 
despite its lower weight fraction in the material. The covalently attached 
biomolecule was not lost during the reaction with glucose and activity of the 
conjugate material lasted through 5 consecutive experiment performed with the 
same sample. 
